Elevance Health, Inc. ELV
Set alert
412.36 USD -1.24 -0.30%
As of Nov 3, 3:12 PM ET
411.84 Day range 417.39
280.74 52-week range 445.28
- YTD
- +17.63%
- 1 year
- +31.66%
- Open
- 412.82
- Prev close
- 413.60
- Mkt cap
- 89.41B
- Vol
- 468.96K
- Avg vol
- 1.18M
- EPS
- 23.55
- P/E
- 17.51
- Div yield
- 1.63%
More statistics
- Low
- 411.84
- High
- 417.39
- Forward P/E
- 13.66
- Beta
- 0.63
- Short ratio
- 4.04
- Inst. own
- 94.68%
- Dividend
- 6.88
- Ex-div date
- Dec 3, 2026
- Earnings
- Jan 27, 2027
- 50-d avg
- 410.56
- 200-d avg
- 372.35
- 1y target
- 482.38
3M chart
Events in this range
- Sep 10, 2026Dividend: 1.72
- Oct 21, 2026Earnings: 6.99; estimate 4.71; surprise 48.41%
- Oct 22, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 22, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Oct 22, 2026Rating: Guggenheim · Buy → Buy
- Oct 22, 2026Rating: UBS · Buy → Buy
- Oct 23, 2026Rating: TD Cowen · Buy → Buy
- Oct 27, 2026Rating: Wells Fargo · Overweight → Overweight
Signals (27)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 3, 2026 | 5 hours ago |
| MACD: Sell Signal | Oct 28, 2026 | 6 days ago |
| RSI: Overbought | Oct 22, 2026 | 1 week ago |
| RSI: Overbought | Oct 20, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
Newest 20 of 27.
Analyst view
Consensus: buy
Buy
Price target (mean) 482.38 +17.0% upside
Now 412.36
- Target (low)
- 406.00
- Target (mean)
- 482.38
- Target (high)
- 523.00
Ratings (0m) 22 15 buy · 7 hold · 0 sell
- Strong buy3
- Buy12
- Hold7
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.07 | 1.64 – 3.22 | 3.33 | -37.9% | 49.14B | -0.3% | 20 |
| Next quarter | 12.32 | 8.69 – 13.23 | 12.58 | -2.1% | 50.06B | +1.1% | 14 |
| Current year | 29.14 | 28.65 – 30.28 | 30.29 | -3.8% | 198.85B | +0.6% | 21 |
| Next year | 30.29 | 29.95 – 31.75 | 29.14 | +3.9% | 203.75B | +2.5% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 23, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 22, 2026 | UBS | Maintained | Buy | Buy |
| Oct 22, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 22, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 22, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 22, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Baird | Maintained | Neutral | Neutral |
| Oct 12, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 17, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jul 17, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Jul 16, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 16, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 16, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 16, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 16, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 14, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 14, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 9, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 7, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 2, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 4, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jun 4, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jun 1, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 26, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 22, 2026 | UBS | Maintained | Buy | Buy |